Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of GADD34 and Type I IFN Response Gene Expression in Patients Suffering From Systemic Lupus Erythematosus

NCT03206359 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT03206359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03206359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of GADD34 and Type I IFN Response Gene Expression in Patients Suffering From Systemic Lupus Erythematosus
Lead sponsor
University Hospital, Grenoble
Phase
Observational
Overall status
Completed
Start date
January 25, 2012
Completion date
April 3, 2015
Enrollment
90 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus